These data are consistent with [3H]CHDI-180 binding to both the recombinant HTT aggregates and mHTT aggregates formed in the brains of zQ175 HD animals and support the use of the RAFTA assay to help characterize and quantify the binding of small molecules to brain homogenates from HD animal models. Here, HTT is linked to Huntington disease.